Thanks for your question. We will answer you soon.
What is the goal of diabetes treatment?
Samuel Dagogo-Jack, MD
The University of Tennessee Health Science Center, Memphis, TN

Date Added: 07/03/13

The goal of diabetes treatment is defined by a special test called A1c test. The A1c tests puts together the highs and lows in blood sugar and crunches the numbers over a period of 90 days, the preceding 90s and reads out one value. It’s scored in a different scale than the blood sugar scale. Thi...
---------------------------------------------------------- ----------------------------------------------------------
Samuel Dagogo–Jack is Professor of Medicine and Director, Division of Endocrinology, Diabetes and Metabolism, and Director, Clinical Research Center at the University of Tennessee Health Science Center, Memphis, where he holds the A.C. Mullins Endowed Chair in Translational Research. He has been a volunteer for the American Diabetes Association for more than 20 years and has served at the national level on the Council of Complications, the Legal Advocacy Council, the Publications Policy Committee as well as the Scientific and Medical Advisory Group. He was also Associate Editor of Diabetes Care, a chapter author in An Uncomplicated Guide to Diabetes Complications and has been an abstract reviewer for Scientific Sessions since 2000. As a member (and later Chair) of the Research Grant Review Committee from 2007 to 2012, Dagogo-Jack played a key role in reviewing and selecting the very best scientific proposals for research funding. He currently serves on the national Board of Directors and Chaired the Research Grant Review Committee from 2009 to 2012. At the local level, Dagogo-Jack has served on Community Leadership Boards in St. Louis and Tennessee and speaks at several local churches and community diabetes education events. His current research, which is supported by the National Institutes of Health and a Mentor–Based Award from the American Diabetes Association, focuses on diabetes prevention and prediction in multiethnic populations utilizing several methodologies that track metabolic processes in humans. Previously, his work with Philip E. Cryer, MD, at Washington University helped define the syndrome of hypoglycemia–associated autonomic failure and the approach to reversal of hypoglycemia unawareness in people with diabetes. Dagogo-Jack holds an MD and a second doctorate in medical research from the University of Ibadan College of Medicine in Nigeria, an MSc from the University of Newcastle‚ and is a Fellow of the Royal College of Physicians of London, the American College of Physicians and the American College of Endocrinology. He is board certified in Internal Medicine, Endocrinology, Diabetes and Metabolism. He is a member of the American Diabetes Association's Pinnacle Society.
Views:
1,205
Have Additional Questions About Diabetes?
Get answers from our physicians
Thank you for your question, and for helping us make this Diabetes Community more robust and helpful to patients like yourself. We'll be in touch soon.